Task: Answer the multiple choice question.
Question: Which drug exhibits a 3.803% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Fc1ccc(-c2n[nH]c(=S)n2Cc2ccccc2)cc1
b: Cc1nn(C)cc1C(=O)N(C)C12CC3CC(CC(C3)C1)C2
Answer: b. Cc1nn(C)cc1C(=O)N(C)C12CC3CC(CC(C3)C1)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(C)cc1C(=O)N(C)C12CC3CC(CC(C3)C1)C2
Cc1nn(C)cc1C(=O)N(C)C12CC3CC(CC(C3)C1)C2
N-(1-adamantyl)-N,1,3-trimethylpyrazole-4-carboxamide